ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 133 filers reported holding ATEA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $859,563 | +1706.6% | 212,763 | +1263.9% | 0.00% | – |
| Q4 2023 | $47,580 | -63.4% | 15,600 | -64.0% | 0.00% | – |
| Q3 2023 | $130,152 | -48.7% | 43,384 | -36.0% | 0.00% | – |
| Q2 2023 | $253,535 | +104235.4% | 67,790 | -6.7% | 0.00% | – |
| Q1 2023 | $243 | -71.9% | 72,658 | -59.6% | 0.00% | – |
| Q4 2022 | $864 | -100.0% | 179,686 | +55.3% | 0.00% | -100.0% |
| Q3 2021 | $4,055,000 | +102.5% | 115,671 | +256.8% | 0.00% | +100.0% |
| Q1 2021 | $2,002,000 | – | 32,420 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 5,462,079 | $16,659,341 | 12.62% |
| TANG CAPITAL MANAGEMENT LLC | 4,076,741 | $12,434,060 | 1.15% |
| Stonepine Capital Management, LLC | 839,514 | $2,560,518 | 1.11% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,581,196 | 0.73% |
| CM Management, LLC | 270,000 | $823,500 | 0.66% |
| EcoR1 Capital, LLC | 6,995,861 | $21,337,376 | 0.55% |
| Acuitas Investments, LLC | 171,098 | $615,373 | 0.32% |
| Newtyn Management, LLC | 508,474 | $1,550,846 | 0.30% |
| Diametric Capital, LP | 161,524 | $492,648 | 0.30% |
| Auour Investments LLC | 177,000 | $670,830 | 0.26% |